CMS’s Verma outlines new drug payment options
CMS Administrator Seema Verma Thursday outlined three types of payment arrangements the agency is considering for new, expensive medicines, such as gene therapies.
Speaking at the Brookings Institution, Verma said CMS may modify its regulations to allow for Medicare to pay for a “drug over time only if a...